Last reviewed · How we verify

minocycline topical gel

BioPharmX, Inc. · Phase 2 active Small molecule

minocycline topical gel is a Small molecule drug developed by BioPharmX, Inc.. It is currently in Phase 2 development. Also known as: minocycline, Dentomycin oral gel will be delivered locally in the periodontal pocket.

At a glance

Generic nameminocycline topical gel
Also known asminocycline, Dentomycin oral gel will be delivered locally in the periodontal pocket
SponsorBioPharmX, Inc.
ModalitySmall molecule
PhasePhase 2

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about minocycline topical gel

What is minocycline topical gel?

minocycline topical gel is a Small molecule drug developed by BioPharmX, Inc..

Who makes minocycline topical gel?

minocycline topical gel is developed by BioPharmX, Inc. (see full BioPharmX, Inc. pipeline at /company/biopharmx-inc).

Is minocycline topical gel also known as anything else?

minocycline topical gel is also known as minocycline, Dentomycin oral gel will be delivered locally in the periodontal pocket.

What development phase is minocycline topical gel in?

minocycline topical gel is in Phase 2.

Related